Skip to main content

Table 7 Gene expression data for fatty acid oxidation pathway genes in adipose from CL-316,243 treated MKR vs vehicle treated MKR mice

From: The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

Gene name

TR vs MKR

Gene name

TR vs MKR

Gene name

TR vs MKR

ALDH1A2

−5.1818

DCXR

−1.6946

SLC27A1

NA

ALDH1A1

−4.1157

ACSL1

−1.5251

ACSL4

NA

SLC27A4

−3.8033

ADHFE1

1.52237

CPT2

NA

ALDH2

−3.7982

HSD17B4

1.54675

ACADM

NA

CPT1A

−3.6059

SLC27A6

1.60681

ACADL

NA

ACSL5

−3.0073

ACAT1

1.89588

HSD17B8

NA

ACOX3

−2.7208

ACSBG2

1.89683

ACADVL

NA

ALDH7A1

−2.5909

ADH6A

2.02657

EHHADH

NA

ALDH3A2

−2.3444

ACAA1

2.02752

ECHS1

NA

IVD

−2.2947

ACSL6

2.10495

HADHA

NA

ACOX1

−2.0718

SLC27A5

2.51732

HADHB

NA

ADH5

−1.9237

SDS

2.65876

HSD17B10

NA

CYP2E1

−1.7096

ACSBG1

NA

  
  1. NA corresponds to that gene expression data was not available in the cut-off dataset (Fold-change > 1.5X and p-value < 0.05). TR denotes CL-316,243 treated MKR mice, MKR denotes vehicle treated MKR mice.